SSMXY SYSMEX CORP UNSP ADR EA REPR 1/2 ORD SHSWatchlist
About SYSMEX CORP UNSP ADR EA REPR 1/2 ORD SHS Company
Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. The firm also offers clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. The firm operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.
Fujirebio and Sysmex Expand CDMO Partnership Into the Field of Neurodegenerative Diseases Under Their Immunoassay Collaboration
Fujirebio Holdings, Inc. (President & CEO: Goki Ishikawa) and Sysmex Corporation (President: Kaoru Asano) today announced that they have entered into an agreement to expand their Contract Development and
Urine Cell Analyzer Market Analysis 2023-2028, Profiles of Leading Players Abbott, Sysmex, Siemens Healthcare, ACON Laboratories, ARKRAY, Shenzhen Mindray Bio-Medical Electronics and More
The "Urine Cell Analyzer Market: Trends, Opportunities and Competitive Analysis 2023-2028" report has been added to ResearchAndMarkets.com's offering....
Sysmex Unit Plans to Acquire Shares in IVD Medical's Subsidiary
Sysmex's (TYO:6869) unit, Sysmex Shanghai, plans to inject capital to and become a shareholder of IVD Medical Holding's (HKG:1931) subsidiary, Vastec Medical Equipment (Shanghai), as part of a coopera